212 related articles for article (PubMed ID: 22457708)
1. Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism.
Nader N; Ng SS; Wang Y; Abel BS; Chrousos GP; Kino T
PLoS One; 2012; 7(3):e26751. PubMed ID: 22457708
[TBL] [Abstract][Full Text] [Related]
2. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events.
Svärd J; Blanco F; Nevin D; Fayne D; Mulcahy F; Hennessy M; Spiers JP
Br J Pharmacol; 2014 Jan; 171(2):480-97. PubMed ID: 24372550
[TBL] [Abstract][Full Text] [Related]
5. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
6. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
[TBL] [Abstract][Full Text] [Related]
9. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
[TBL] [Abstract][Full Text] [Related]
11. Activation of liver X receptor attenuates endothelin-1 expression in vascular endothelial cells.
Gao M; Zeng Y; Guan Y; Hu Z; Zhong D; Shen X; Zhang L; Xu Z; Gong W; Zhang Y; Zhang M; Zheng Y; He F
Int J Biochem Cell Biol; 2012 Dec; 44(12):2299-307. PubMed ID: 23018104
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid response and promoter occupancy of the mouse LXRalpha gene.
Steffensen KR; Holter E; Alikhani N; Eskild W; Gustafsson JA
Biochem Biophys Res Commun; 2003 Dec; 312(3):716-24. PubMed ID: 14680824
[TBL] [Abstract][Full Text] [Related]
13. LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice.
Patel R; Patel M; Tsai R; Lin V; Bookout AL; Zhang Y; Magomedova L; Li T; Chan JF; Budd C; Mangelsdorf DJ; Cummins CL
J Clin Invest; 2011 Jan; 121(1):431-41. PubMed ID: 21123945
[TBL] [Abstract][Full Text] [Related]
14. The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications.
Ichijo T; Voutetakis A; Cotrim AP; Bhattachryya N; Fujii M; Chrousos GP; Kino T
J Biol Chem; 2005 Dec; 280(51):42067-77. PubMed ID: 16249187
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.
Bindesbøll C; Fan Q; Nørgaard RC; MacPherson L; Ruan HB; Wu J; Pedersen TÅ; Steffensen KR; Yang X; Matthews J; Mandrup S; Nebb HI; Grønning-Wang LM
J Lipid Res; 2015 Apr; 56(4):771-85. PubMed ID: 25724563
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.
Saladin R; Vu-Dac N; Fruchart JC; Auwerx J; Staels B
Eur J Biochem; 1996 Jul; 239(2):451-9. PubMed ID: 8706754
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary.
Matsumoto S; Hashimoto K; Yamada M; Satoh T; Hirato J; Mori M
Mol Endocrinol; 2009 Jan; 23(1):47-60. PubMed ID: 19036902
[TBL] [Abstract][Full Text] [Related]
18. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
[TBL] [Abstract][Full Text] [Related]
20. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
